Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: A review of the literature

Fundamental and Clinical Pharmacology

Volumn 21, Issue 5, 2007, Pages 459-466

  Roussin, Anne ^a   Montastruc, Jean Louis ^a   Lapeyre Mestre, Maryse ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Abuse; Pharmacodependence; Propofol

Indexed keywords

ALCOHOL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; DOPAMINE; DRONABINOL; KETAMINE; METHOHEXITAL; METHYLPHENIDATE; MIDAZOLAM; NITROUS OXIDE; PLACEBO; PROPOFOL;

ABNORMAL DREAMING; APNEA; CLINICAL TRIAL; CONFUSION; CONTINUOUS INFUSION; DEATH; DIZZINESS; DOPAMINE BRAIN LEVEL; DRUG DEPENDENCE; DRUG EFFECT; DRUG INTOXICATION; DRUG MECHANISM; DRUG SELF ADMINISTRATION; DRUG TARGETING; DRUG WITHDRAWAL; EUPHORIA; EXPERIMENTAL STUDY; FATIGUE; GENERAL ANESTHESIA; HALLUCINATION; HEALTH PRACTITIONER; HUMAN; IN VIVO STUDY; INHIBITION (PSYCHOLOGY); INTRAVENOUS DRUG ABUSE; LUNG EDEMA; MOLECULAR BIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PANCREATITIS; PLACE PREFERENCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RECREATION; REINFORCEMENT; RESPIRATION DEPRESSION; REVIEW; REWARD; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; WITHDRAWAL SYNDROME;

EID: 34548656743     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00497.x     Document Type: Review

References (69)

1. Martindale: The complete drug reference, 34th edn, Sweetman S.C., London, 2005, pp. 1305 1307.
2. Iwersen-Bergmann S., Rosner P., Kuhnau H.C., Junge M., Schmoldt A. Death after excessive propofol abuse. Int. J. Legal Med. (2001) 114 248 251.
3. Payne K., Moore E.W., Elliott R.A., Pollard B.J., McHugh G.A. Anaesthesia for day case surgery: a survey of adult clinical practice in the UK. Eur. J. Anaesthesiol. (2003) 20 311 324.
4. Girard C., Mauriat P., Goudeau J.-J. et al. Anesthesie-Reanimation- Techniques en Chirurgie Cardiaque. [Anaesthesia and intensive care for cardiac surgery in France: results of the three days national survey realised in 2001 by the club of Anaesthesia, Intensive Care and Techniques in Cardiac Surgery (ARTECC)]. Ann. Fr. Anesth. Reanim. (2004) 23 862 872.
5. Drummer O.H. A fatality due to propofol poisoning. J. Forensic Sci. (1992) 37 1186 1189.
6. Gundel H., Kuhs H. Kasuistische Mitteilung über neuntägigen Propofol-Mi[beta]brauch [Case report on a nine-day propofol abuse]. Anaesthesiol. Intensivmed. Schmerztherap. (1992) 27 181 182.
7. Follette J.W., Farley W.J. Anaesthesiologist addicted to propofol. Anesthesiology (1992) 77 817 818.
8. Soyka M., Schütz C.G. Propofol dependency (letter). Addiction (1997) 92 1369 1370.
9. Odell M. Propofol abuse (letter). Anaesth. Intensive Care (1999) 27 539.
10. Fritz G.A., Niemczyk W.E. Propofol dependency in a lay person [Case reports]. Anesthesiology (2002) 96 505 506.
11. Cirimele V., Kintz P., Doray S., Ludes B. Determination of chronic abuse of the anaesthetic agents midazolam and propofol as demonstrated by hair analysis. Int. J. Legal Med. (2002) 116 54 57.
12. Roussin A., Mirepoix M., Lassabe G. et al. Death related to a recreational abuse of propofol at therapeutic dose range. Br. J. Anaesth. (2006 97 268.
13. Beaujouan L., Czernichow S., Pourriat J.L., Bonnet F. Prevalence and risk factors for substance abuse and dependence among anaesthetists: a national survey. Ann. Fr. Anesth. Reanim. (2005) 24 471 479.
14. Luck S., Hedrick J. The alarming trend of substance abuse in anaesthesia providers. J. Perianesth. Nurs. (2004) 19 308 311.
15. Krasowski M.D., Harrison N.L. General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci. (1999) 55 1278 1303.
16. Krasowski M.D., Koltchine V.V., Rick C.E., Ye Q., Finn S.E., Harrison N.L. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol. Pharmacol. (1998) 53 530 538.
17. Sonner J.M., Zhang Y., Stabernack C., Abaigar W., Xing Y., Laster M.J. GABA(A) receptor blockade antagonizes the immobilizing action of propofol but not ketamine or isoflurane in a dose-related manner. Anesth. Analg. (2003) 96 706 712.
18. Irifune M., Sugimura M., Takarada T. et al. Propofol anaesthesia in mice is potentiated by muscimol and reversed by bicuculline. Br. J. Anaesth. (1999) 83 665 667.
19. Irifune M., Takarada T., Shimizu Y. et al. Propofol-induced anesthesia in mice is mediated by gamma-aminobutyric acid-A and excitatory amino acid receptors. Anesth. Analg. (2003) 97 424 429.
20. Hales T.G., Lambert J.J. The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones. Br. J. Pharmacol. (1991) 104 619 628.
21. Mascia M.P., Machu T.K., Harris R.A. Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br. J. Pharmacol. (1996) 119 1331 1336.
22. Pistis M., Belelli D., Peters J.A., Lambert J.J. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. Br. J. Pharmacol. (1997) 122 1707 1719.
23. Orser B.A., Bertlik M., Wang L.Y., MacDonald J.F. Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-d-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br. J. Pharmacol. (1995) 116 1761 1768.
24. Kingston S., Mao L., Yang L., Arora A., Fibuch E.E., Wang J.Q. Propofol inhibits phosphorylation of N-methyl-d-aspartate receptor NR1 subunits in neurons. Anesthesiology (2006) 104 763 769.
25. White J.M., Ryan C.F. Pharmacological properties of ketamine. Drug Alcohol Rev. (1996) 15 145 155.
26. Pakrashi T.C., Park G.R.(2004) Fantasmes sexuels: un cauchemar anaesthésique. Le praticien en anesthésie-réanimation (2004) 8 349 354.
27. Brazolotto I. Effects of propofol. Ann. Fr. Anesth. Reanim. (1989) 8 388.
28. Patel S., Wohlfeil E.R., Rademacher D.J. et al. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br. J. Pharmacol. (2003) 139 1005 1013.
29. Tsutsumi S., Tomioka A., Sudo M. et al. Propofol activates vanilloid receptor channels expressed in human embryonic kidney 293 cells. Neuroscience (2001) 312 45 49.
30. Roy A.W. Dopamine, learning and motivation. Nat. Rev. Neurosci. (2004) 5 483 494.
31. Pain L., Gobaille S., Schleef C., Aunis D., Oberling P. In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth. Analg. (2002) 95 915 919.
32. Pain L., Oberling P., Launoy A., Di Scala G. Effect of nonsedative doses of propofol on an innate anxiogenic situation in rats. Anesthesiology (1999) 90 191 196.
33. Schulte D., Callado L.F., Davidson C. et al. Propofol decreases stimulated dopamine release in the rat nucleus accumbens by a mechanism independent of dopamine D2, GABAA and NMDA receptors. Br. J. Anaesth. (2000) 84 250 253.
34. Keita H., Lecharny J.B., Henzel D., Desmonts J.M., Mantz J. Is inhibition of dopamine uptake relevant to the hypnotic action of i.v. anaesthetics Br. J. Anaesth. (1996) 77 254 256.
35. Pain L., Oberling P., Sandner G., Di Scala G. Effect of propofol on affective state as assessed by place conditioning paradigm in rats. Anesthesiology (1996) 85 121 128.
36. Pain L., Oberling P., Sandner G., Di Scala G. Effect of midazolam on propofol-induced positive affective state assessed by place conditioning in rats. Anesthesiology (1997) 87 935 943.
37. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward Psychopharmacology (Berl.) (2000) 153 31 43.
38. Ator N.A., Griffiths R.R. Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend. (2003) 70 S55 72.
39. Committee for medicinal products for human use. Guideline of the non-clinical investigation of the dependence potential of medicinal products 2006) http://www.emea.eu.int/pdfs/human/swp/9422704en.pdf. [last accessed 16 April 2007]
40. Le Sage M.G., Stafford D., Glowa J.R. Abuse liability of the anaesthetic propofol: self-administration of propofol in rats under fixed-ratio schedules of drug delivery. Psychopharmacology (Berl.) (2000) 153 148 154.
41. Weerts E.M., Ator N.A., Griffiths R.R. Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons. Drug Alcohol Depend. (1999) 57 51 60.
42. Blokhina E.A., Dravolina O.A., Bespalov A.Y., Balster R.L., Zvartau E.E. Intravenous self-administration of abused solvents and anesthetics in mice. Eur. J. Pharmacol. (2004) 485 211 218.
43. Sanchis-Segura C., Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict. Biol. (2006) 11 2 38.
44. Zacny J.P., Lichtor J.L., Zaragoza J.G. et al. Assessing the behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. Drug Alcohol Depend. (1993) 32 45 57.
45. Zacny J.P., Lichtor J.L., Thompson W., Apfelbaum J.L. Propofol at subanaesthetic doses may have abuse potential in healthy volunteers. Anesth. Analg. (1993) 77 544 552.
46. De Wit H., Uhlenhuth E.H., Johanson C.E. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend. (1986) 16 341 360.
47. Dohrn C.S., Lichtor J.L., Coalson D.W., Uitvlugt A., de Wit H., Zacny J.P. Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug Alcohol Depend. (1993) 31 265 280.
48. Stern K.N., Chait L.D., Johanson C.E. Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology (Berl.) (1989) 98 81 88.
49. Uhlenhuth E.H., Johanson C.E., Kilgore K., Kobasa S.C. Drug preference and mood in humans: preference for d-amphetamine and subject characteristics. Psychopharmacology (Berl.) (1981) 74 191 194.
50. Chait L.D., Zacny J.P. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans. Psychopharmacology (Berl.) (1992) 107 255 262.
51. Chait L.D. Reinforcing and subjective effects of methylphenidate in humans. Behav. Pharmacol. (1994) 5 281 288.
52. Zacny J.P., Lichtor J.L., Coalson D.W. et al. Subjective and psychomotor effects of subanesthetic doses of propofol in healthy volunteers. Anesthesiology (1992) 76 696 702.
53. Brandner B., Blagrove M., McCallum G., Bromley L.M. Dreams, images and emotions associated with propofol anaesthesia. Anaesthesia (1997) 52 750 755.
54. Hellwagner K., Holzer A., Gustorff B. et al. Recollection of dreams after short general anaesthesia: influence on patient anxiety and satisfaction. Eur. J. Anaesthesiol. (2003) 20 282 288.
55. Marsch S.C., Schaefer H.G., Tschan C., Meier B. Dreaming and anaesthesia: total i.v. anaesthesia with propofol vs. balanced volatile anaesthesia with enflurane. Eur. J. Anaesthesiol. (1992) 9 331 333.
56. Kasmacher H., Petermeyer M., Decker C. Incidence and quality of dreaming during anaesthesia with propofol in comparison with enflurane. Anaesthesist (1996) 45 146 153.
57. Schneider U., Rada D., Rollnik J.D., Passie T., Emrich H.M. Propofol dependency after treatment of tension headache. Addict. Biol. (2001) 6 263 265.
58. Au J., Walker W.S., Scott D.H. Withdrawal syndrome after propofol infusion. Anaesthesia (1990) 45 741 742.
59. Imray J.M., Hay A. Withdrawal syndrome after propofol. Anaesthesia (1991) 46 704.
60. Cawley M.J., Guse T.M., Laroia A., Haith L.R., Ackerman B.H. Propofol withdrawal syndrome in an adult patient with thermal injury. Pharmacotherapy (2003) 23 933 939.
61. Chao T.C., Lo D.S., Chui P.P., Koh T.H. The first fatal 2,6-di-isopropylphenol (propofol) poisoning in Singapore: a case report. Forensic Sci. Int. (1994) 66 1 7.
62. Baudoin Z. General anaesthetics and anaesthetic gases, in : Dukes M.N.G.& Aronson J.K. (Eds Meyler's side effects of drugs, 14th edn, Elsevier, Amsterdam, 2000, 330 pp.
63. Gillies G.W.A., Lees N.W. The effects of speed of injection of propofol. A comparison with etidomate. Anaesthesia (1989) 44 386 388.
64. Tai Y.T., Yao C.T., Yang Y.J. Acute pulmonary edema after intravenous propofol sedation for endoscopy in a child. J. Pediatr. Gastroenterol. Nutr. (2003) 37 320 322.
65. Kumar A.N., Schwartz D.E., Lim K.G. Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge. Chest (1999) 115 1198 1199.
66. Devlin J.W., Lau A.K., Tanios M.A. Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy (2005) 25 1348 1352.
67. Possidente C.J., Rogers F.B., Osler T.M. Elevated pancreatic enzymes after extended propofol therapy. Pharmacotherapy (1998) 18 653 655.
68. Jawaid Q., Presti M.E., Neuschwander-Tetri B.A., Burton F.R. Acute pancreatitis after single-dose exposure to propofol: a case report and review of literature. Dig. Dis. Sci. (2002) 47 614 618.
69. Gottschling S., Larsen R., Meyer S., Graf N., Reinhard H. Acute pancreatitis induced by short-term propofol administration. Paediatr. Anaesth. (2005) 15 1006 1008.